Flares in Osteoarthritis Working Group

About

Many patients have been suggesting that traditional outcome measures and instruments do not capture all their experiences of living with their OA of the hips and knees, such like intermittent episodes or ‘flares’ of their disease. There are many other features beyond pain that can occur during these episodes, that have a big impact on their quality of life.
The key aim of the OA Flare Working Group is first, to identify the domains of Hip or Knee OA flare using OMERACT methodology. Second, to follow this with developing a composite measure, incorporating these domains.

Current Stage in the OMERACT Process

The Flare-OA group is testing and refining its composite questionnaire, which measures flare experiences beyond pain alone. Studies on responsiveness and weighting are underway to prepare the measure for endorsement.

Latest Update

Recent Milestones Achieved
  • One randomized clinical trial and five cohort studies are underway, with over 450 patients enrolled.
  • Protocols for determining both weights and severity thresholds have been finalized and approved by the Flare-OA group. These protocols are currently under review by an ethics committee.
Upcoming Activities and Deliverables
  • Continued data collection from the ongoing randomized clinical trial and five cohort studies (totaling over 450 participants) to assess responsiveness.
  • Initiation of studies based on the approved protocols for determining dimension weights and severity thresholds, pending ethics approval.
Composites Roadmap (1)

Meet the Team

Francis Guillemin

Francis Guillemin, France
Chair

Lyn March

Lyn March, Australia
Chair

Lauren King

Lauren King, Canada
Chair

Thomas Buttel

Tom Buttel, Australia
Patient Research Partner

Sam Michel Cembalo

Sam Michel Cembalo, France
Patient Research Partner

generic-person-icon-1

Cynthia Copenhaver, USA
Patient Research Partner

Recent Publications

  1. Queiroga, Fabiana, et al. “The Flare-OA-16 Questionnaire Measuring Flare in Knee and Hip Osteoarthritis in the Patient Perspective: Scale Reduction and Validation Using a Rasch Model.” Journal of Clinical Epidemiology, vol. 174, 111488, 2024, https://doi.org/10.1016/j.jclinepi.2024.111488.
  2. Queiroga, Fabiana, et al. A Scoping Review of Patient Self-Report Measures of Flare in Knee and Hip Osteoarthritis (OA): A Report from the OMERACT Flares in OA Working Group.” Seminars in Arthritis and Rheumatism, vol. 63, 152281, 2023, https://doi.org/10.1016/j.semarthrit.2023.152281.
  3. Queiroga, F., et al.Assessing Domain Match and Feasibility of Candidate Instruments Matching with OMERACT Endorsed Domains to Measure Flare in Knee and Hip Osteoarthritis.” Seminars in Arthritis and Rheumatism, vol. 65, 152371, 2024, https://doi.org/10.1016/j.semarthrit.2024.152371.
  4. King, Lauren K., et al. Endorsement of the Domains of Knee and Hip Osteoarthritis (OA) Flare: A Report from the OMERACT 2020 Inaugural Virtual Consensus Vote from the Flares in OA Working Group.” Seminars in Arthritis and Rheumatism, vol. 51, no. 3, 2021, pp. 618–22, https://doi.org/10.1016/j.semarthrit.2021.03.010.
  5. Guillemin, Francis, et al. “Developing a Preliminary Definition and Domains of Flare in Knee and Hip Osteoarthritis (OA): Consensus Building of the Flare-in-OA OMERACT Group.” Journal of Rheumatology, vol. 46, no. 9, 2019, pp. 1188–91, https://doi.org/10.3899/jrheum.181085.
  6. Cross, Marita, et al. “Defining Flare in Osteoarthritis of the Hip and Knee: A Systematic Literature Review — OMERACT Virtual Special Interest Group.” Journal of Rheumatology, vol. 44, no. 12, 2017, pp. 1920–27, https://doi.org/10.3899/jrheum.161107.

New to OMERACT?

OMERACT Working Groups follow a structured, consensus-driven approach to developing Core Outcome Sets. Explore how this process unfolds and discover more about how OMERACT advances outcome measurement in rheumatology.

Scroll to Top